InflaRx (IFRX) Exchange Rate Effect (2016 - 2026)
InflaRx's (IFRX) quarterly Exchange Rate Effect came in at $351429.7 in Q1 2026, up 119.21% year-on-year from $160313.5 in Q1 2025, and up 427.37% quarter-over-quarter from -$107348.1 in Q4 2025.
InflaRx (IFRX) Exchange Rate Effect (2016 - 2026) Analysis & Trends
InflaRx has disclosed Exchange Rate Effect across 11 years of filings, most recently posting $351429.7 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $351429.7, up 119.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 148.49% YoY), and the FY2025 annual result was -$4.2 million, down 376.52% from the prior year.
- Exchange Rate Effect came in at $351429.7 for Q1 2026 at InflaRx, up from -$107348.1 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.0 million in Q2 2022 to a low of -$2.0 million in Q2 2025.
- The 5-year median for Exchange Rate Effect is -$40102.1 (2025), against an average of -$29687.7.
- Across the five-year window, Exchange Rate Effect surged 463.79% in 2024 and slumped 710.66% in 2025, its largest moves.
- InflaRx's Exchange Rate Effect stood at -$523806.2 in 2022, then plunged by 60.92% to -$842905.3 in 2023, then soared by 281.52% to $1.5 million in 2024, then slumped by 107.02% to -$107348.1 in 2025, then jumped by 427.37% to $351429.7 in 2026.
- The last three Exchange Rate Effect figures came in at $351429.7 (Q1 2026), -$107348.1 (Q4 2025), and -$40102.1 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | 351,429.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 351,429.75 |
| Mar 31, 2026 | 351,429.75 |
| Dec 31, 2025 | -107,348.09 |
| Dec 31, 2025 | -107,348.09 |
| Sep 30, 2025 | -40,102.10 |
| Sep 30, 2025 | -40,102.10 |
| Jun 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | -723,771.68 |
| Sep 30, 2024 | -723,771.68 |
| Jun 30, 2024 | 319,540.54 |
| Jun 30, 2024 | 319,540.54 |
| Mar 31, 2024 | 374,122.35 |
| Mar 31, 2024 | 374,122.35 |
| Dec 31, 2023 | -842,905.31 |
| Dec 31, 2023 | -842,905.31 |